ICON plc
ICLR
Positions held
Your positionsICLR isn't in your positions.
Add it to see shares, cost, and P&L here.
Bull / bear case
Site-generated summary from fundamentals, news, and score — not investment advice. As of 2026-10-08.
- ICON plc operates in the growing diagnostics and research sector, which is essential for advancing healthcare solutions and has a strong market position.
- Revenue increased by 1% compared to the prior quarter, reaching $2.1 billion.
- The company has a PEG ratio of 0.51, indicating potential for growth relative to its earnings.
- The company's earnings growth has declined significantly, with a -63.3% change year-over-year.
- Net income for the most recent quarter was $72.582 million, down from $104.751 million in the previous quarter.
- The operating margin has decreased to 9.41% from 11.96% in the prior quarter.
Fundamentals
| Market cap | $12.69B | Enterprise value | $15.29B | Trailing P/E | 173.16 | Forward P/E | 13.93 |
| PEG | 0.50 | Price / book | 1.35 | Beta | 1.24 | Dividend yield | 0.00% |
| Revenue growth | 1.2% | Earnings growth | -63.3% | Gross margin | 23.9% | Operating margin | 9.4% |
| Profit margin | 0.3% | ROE | 0.3% | ROA | 1.0% | Debt / equity | 0.38 |
| Current ratio | 0.95 | Free cash flow | $622.65M | Analyst recommendation | buy | Mean target | $184.41 |
| 52w high | $203.91 | 52w low | $66.57 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | |
|---|---|---|---|---|---|---|
| Revenue | $2.1B | $2.0B | $2.2B | $2.1B | $2.0B | — |
| Op margin | 9.4% | 9.2% | 10.5% | 12.0% | 13.8% | — |
| Net income | $72.6M | $105M | -$110M | -$284M | $204M | — |
| Gross margin | 23.2% | 23.5% | 22.9% | 26.2% | 28.6% | — |
| Gross profit | $479M | $478M | $501M | $545M | $583M | — |
| Operating income | $194M | $187M | $230M | $249M | $281M | — |
- Revenue +1% vs prior quarter ($2.1B vs $2.0B).
- Gross margin 23.2% (was 23.5% prior quarter).
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $8.3B | $8.2B | $8.1B | $7.7B | — |
| Op margin | 12.3% | 14.1% | 12.3% | 11.2% | — |
| Net income | $229M | $739M | $554M | $505M | — |
| Gross margin | 26.4% | 29.0% | 29.2% | 28.6% | — |
| Gross profit | $2.2B | $2.4B | $2.3B | $2.2B | — |
| Operating income | $1.0B | $1.2B | $994M | $866M | — |
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
2026-10-08 · ICON Schedules Third Quarter 2026 Earnings Conference Call
2026-09-30 · UBS Downgrades ICON to Neutral From Buy
2026-09-22 · ICON Public Limited Company’s (ICLR) Shrinking Moat Warranted an Early Departure
2026-09-18 · Icon Insider Sold Shares Worth $875,875, According to a Recent SEC Filing
2026-09-18 · Icon Insider Sold Shares Worth $569,625, According to a Recent SEC Filing
2026-09-18 · Icon Insider Sold Shares Worth $875,875, According to a Recent SEC Filing
2026-09-04 · CVS Health (CVS) Up 1% Since Last Earnings Report: Can It Continue?
2026-08-28 · Icon PLC (ICLR) Up 2.5% Since Last Earnings Report: Can It Continue?
2026-08-20 · ICON Releases 2025 ICON Cares Report, Highlighting Progress in Patient Impact, Innovation and Sustainability
2026-08-14 · Glenn Greenberg's Top Second Quarter 2026 Move: TD Synnex Corp at a -6.73% Portfolio Impact
2026-08-06 · Is ICON a Buy as Valuation Improves but Earnings Risks Still Persist?
2026-08-06 · ICON Announces Pricing of USD 2.15 Billion Notes
Price (daily)
Full chart · RSI · MACD · patterns